Browse the corpus

REFERENCES ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, “Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT),” JAMA , 2002, 288(23):2981-97. [PubMed 12479763 ] Castro C and Gourley M, "Diagnosis and Treatment of Inflammatory Myopathy: Issues and Management," Ther Adv Musculoskelet Dis , 2012, 4(2):111-20. [PubMed 22870499 ] de Denus S and Spinler SA, “Early Statin Therapy for Acute Coronary Syndromes,” Ann Pharmacother , 2002, 36(11):1749-58. [PubMed 12398573 ] “Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” JAMA , 2001, 285(19):2486-97. [PubMed 11368702 ] Fleisher LA, Beckman JA, Brown KA, et al, "2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery," J Am Coll Cardiol , 2009, 54(22):e13-e118. [PubMed 19926002 ] Grundy SM, Cleeman JI, Merz CN, et al, “Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines,” J Am Coll Cardiol , 2004, 44(3):720-32. [PubMed 15358046 ] Heeschen C, Hamm CW, Laufs U, et al, “Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes,” Circulation , 2002, 105(12):1446-52. [PubMed 11914253 ] Hunt SA, Abraham WT, Chin MH, et al, “2009 Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation,” CIrculation , 2009, 119(14):e391-479. [PubMed 19324966 ] LaRosa JC, Grundy SM, Waters DD, et al, “Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease,” N Engl J Med , 2005, 352(14):1425-35. [PubMed 15755765 ]

Hunt SA, Abraham WT, Chin MH, et al, “2009 Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation,” CIrculation , 2009, 119(14):e391-479. [PubMed 19324966 ] LaRosa JC, Grundy SM, Waters DD, et al, “Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease,” N Engl J Med , 2005, 352(14):1425-35. [PubMed 15755765 ] LeManach Y, Godet G, Coriat P, et al, “The Impact of Postoperative Discontinuation or Continuation of Chronic Statin Therapy on Cardiac Outcome After Major Vascular Surgery,” Anesth Analg , 2007, 104(6):1326-33. [PubMed 17513620 ] “MRC/BHF Heart Protection Study of Cholesterol Lowering With Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial. Heart Protection Study Collaborative Group,” Lancet , 2002, 360(9326):7-22. [PubMed 12114036 ] Nissen SE, Tuzcu EM, Libby P, et al, “Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure: The CAMELOT Study: A Randomized Controlled Trial,” JAMA , 2004, 292(18):2217-25. [PubMed 15536108 ] Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al, “ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins,” Stroke , 2002, 33(9):2337-41. Available at file://stroke.ahajournals.org/cgi/content/short/33/9/2337 [PubMed 12215610 ] Poldermans D, Bax JJ, Kertai MD, et al, “Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery,” Circulation , 2003, 107(14):1848-51. [PubMed 12695283 ] Ridker PM, Danielson E, Fonseca FAH, et al, “Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein,” N Engl J Med , 2008, 359(21):2195-207. [PubMed 18997196 ] Sever PS, Dahlof B, Poulter NR, et al, “Prevention of Coronary and Stroke Events With Atorvastatin in Hypertensive Patients Who Have Average or Lower-Than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid-Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial,” Lancet , 2003, 361(9364):1149-58. [PubMed 12686036 ] Topic 8680 Version 50.0

Sever PS, Dahlof B, Poulter NR, et al, “Prevention of Coronary and Stroke Events With Atorvastatin in Hypertensive Patients Who Have Average or Lower-Than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid-Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial,” Lancet , 2003, 361(9364):1149-58. [PubMed 12686036 ] Topic 8680 Version 50.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1103-200.131.240.2-13CD9D8202-S244013.14]